Hepatitis C virus (HCV) infection in the Piacenza dialysis center
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 4)
In a group of 110 dialysis patients, 21% had anti-HCV antibodies. Statistical differences were noted according to method and duration of dialysis as well as the presence of further risk factors.
KeywordsPeritoneal Dialysis Viral Hepatitis Haemodialysis Patient Negative Patient Drug Addict
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.A. M. Couroŭcé et al (1990) Antibodies to hepatitis C virus in haemodialysis patients. Abst. 395, International Symposium on viral hepatitis and liver disease. Houston, Texas, April 4–8, 1990Google Scholar
- 2.U. Schlipköter et al (1990) Prevalence of anti-HCV in Haemodialysis patients in southern Germany. Abst. 397, International Symposium on viral hepatitis and liver disease. Houston, Texas, April 4–8, 1990Google Scholar
© Springer-Verlag 1992